Evidence map›Paper›PMID 27736905›Full record

ArticlePloS one2016

Altered mRNA Splicing in SMN-Depleted Motor Neuron-Like Cells.

Sara K Custer, Timra D Gilson, Hongxia Li, A Gary Todd, Jacob W Astroski, Hai Lin, Yunlong Liu, Elliot J Androphy

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. IL-1ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  4. Article
  5. Article
  6. Mitochondrial Dysfunction in Spinal Muscular Atrophy.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sara K CusterDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Timra D GilsonDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Hongxia LiDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, United States of America.
A Gary ToddDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Jacob W AstroskiDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Hai LinDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Yunlong LiuDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Elliot J AndrophyDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, United States of America.ORCID http://orcid.org/0000-0002-8104-0703
Indiana University School of Medicine

Funding

Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
The COPA vesicle protein and pathogenesis of spinal muscular atrophyR01NS082284 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI ANDROPHY, ELLIOT J. · 2013 to 2023
$3.7M
Training in STIs and infections of global health significanceT32AI007637 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI WOOLS-KALOUSTIAN, KARA KAY · 2001 to 2020
$3.4M
NCATS NIH HHS UL1 TR001108NIAID NIH HHS T32 AI007637NINDS NIH HHS R01 NS082284
6 · The paper itself

Abstract

Spinal muscular atrophy (SMA) is an intractable neurodegenerative disease afflicting 1 in 6-10,000 live births. One of the key functions of the SMN protein is regulation of spliceosome assembly. Reduced levels of the SMN protein that are observed in SMA have been shown to result in aberrant mRNA splicing. SMN-dependent mis-spliced transcripts in motor neurons may cause stresses that are particularly harmful and may serve as potential targets for the treatment of motor neuron disease or as biomarkers in the SMA patient population. We performed deep RNA sequencing using motor neuron-like NSC-34 cells to screen for SMN-dependent mRNA processing changes that occur following acute depletion of SMN. We identified SMN-dependent splicing changes, including an intron retention event that results in the production of a truncated Rit1 transcript. This intron-retained transcript is stable and is mis-spliced in spinal cord from symptomatic SMA mice. Constitutively active Rit1 ameliorated the neurite outgrowth defect in SMN depleted NSC-34 cells, while expression of the truncated protein product of the mis-spliced Rit1 transcript inhibited neurite extension. These results reveal new insights into the biological consequence of SMN-dependent splicing in motor neuron-like cells.

Indexed as

RNA SplicingAnimalsCell LineDisease Models, AnimalExonsFemaleGene Expression RegulationIntronsMaleMiceMice, TransgenicMotor NeuronsMuscular Atrophy, SpinalRNA, MessengerSpinal CordSurvival of Motor Neuron 1 ProteinRNA, MessengerSurvival of Motor Neuron 1 ProteinSurvival of Motor Neuron 2 Protein

Identifiers

PMID27736905
PMCPMC5063418
OpenAlexW2530004925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.